Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC38 | Pictilisib | pan PI3K | PI3K/mTOR | 6.5531 | 0.3569 | 0.1182 | 0.0066 | 0.7184 | 30.2402 | 0.97968 |
HCC38 | Ceritinib | ALK | RTK | 1.8283 | -0.4039 | 0.2184 | 0.0883 | 2.6153 | 2.323 | 0.99573 |
HCC38 | Neratinib | EGFR/HER2 | RTK | 3.1556 | 0.4571 | 0.1019 | 0.0168 | 0.7043 | 15.0154 | 0.87632 |
HCC38 | Tivantinib | MET | RTK | 0.30919 | -0.2702 | 0.4367 | 0.1297 | 1.8013 | 0.39141 | 0.99767 |
HCC38 | Cediranib | VEGFR/cKIT | RTK | 1.5907 | -0.2044 | 0.2096 | 0.0416 | 1.0695 | 3.1564 | 0.98723 |
HCC38 | Cabozantinib | VEGFR2/MET | RTK | 8.2108 | 0.3009 | 0.0376 | 0.0168 | 4.3352 | 8.1748 | 0.98657 |
HCC70 | Abemaciclib | CDK4/6 | Cell cycle | 1.885 | -0.8264 | 0.2315 | 0.0832 | 2.5102 | 2.8439 | 0.99569 |
HCC70 | Palbociclib | CDK4/6 | Cell cycle | Inf | 0.9361 | -0.0281 | -0.0013 | 0.0000 | Inf | -0.054738 |
HCC70 | AZD7762 | CHK1/2 | Cell cycle | 0.040563 | -0.7002 | 0.8995 | 0.3250 | 2.5054 | 0.056277 | 0.99456 |
HCC70 | Volasertib | PLK | Cell cycle | 0.0065224 | -0.2049 | 0.6421 | 0.1395 | 3.2698 | 0.0072379 | 0.9841 |
HCC70 | Dinaciclib | pan CDK | Cell cycle | 0.01286 | -0.9093 | 0.8338 | 0.3254 | 5.0000 | 0.015807 | 0.9991 |
HCC70 | Cisplatin | Chemo | Chemotherapy | 1.3073 | -0.6832 | 0.2650 | 0.0820 | 1.3165 | 3.0116 | 0.99076 |
HCC70 | Doxorubicin | Chemo | Chemotherapy | 0.010621 | -0.7794 | 0.7867 | 0.1459 | 2.0410 | 0.014138 | 0.93856 |
HCC70 | Taxol | Chemo | Chemotherapy | 0.0013411 | -0.5065 | 0.9773 | 0.3742 | 1.1642 | 0.0024269 | 0.99734 |
HCC70 | Topotecan | Topo I | Chemotherapy | 0.0094575 | -0.8614 | 1.0593 | 0.2429 | 0.6102 | 0.049603 | 0.96643 |
HCC70 | Etoposide | Topo II | Chemotherapy | 0.36498 | -0.1518 | 0.4535 | 0.0513 | 2.1004 | 0.41879 | 0.96872 |
HCC70 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.0096376 | -0.5787 | 1.0609 | 0.1267 | 1.0559 | 0.020015 | 0.98982 |
HCC70 | Trametinib | MEK | MAPK/nRTK | 0.0019047 | -0.0393 | 0.6924 | 0.1954 | 0.8693 | 0.0021049 | 0.98467 |
HCC70 | Saracatinib | SRC | MAPK/nRTK | 0.063682 | -0.1718 | 0.5795 | 0.0595 | 0.9276 | 0.081014 | 0.97522 |
HCC70 | ABT-737 | Bcl2/XL | Misc | 2.7474 | -0.0638 | 0.1562 | 0.0632 | 0.9362 | 8.8827 | 0.97385 |
HCC70 | Vorinostat | HDAC | Misc | 0.40578 | -0.4765 | 0.4082 | 0.0748 | 0.8914 | 1.0253 | 0.99218 |
HCC70 | Luminespib | HSP90 | Misc | 0.007646 | -0.5826 | 0.7792 | 0.2409 | 5.0000 | 0.0088695 | 0.99752 |
HCC70 | A-1210477 | Mcl-1 | Misc | Inf | 0.9380 | 0.0054 | 0.0123 | 0.0000 | Inf | 0.17964 |
HCC70 | Olaparib | PARP | Misc | 27.0584 | 0.7191 | 0.0232 | -0.0045 | 0.7530 | 116.2527 | 0.78542 |
HCC70 | Bleomycin | Radiation | Misc | 0.39804 | -0.1146 | 0.4192 | 0.0530 | 0.9765 | 0.54995 | 0.95046 |